Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
スポンサーリンク
概要
- 論文の詳細を見る
- Center for Academic Pub. Japanの論文
- 2006-04-20
著者
-
MUTOH Seitaro
Pharmacology Research Laboratories, Astellas Pharma Inc.
-
Mutoh Seitaro
Pharmacology Res. Labs Astellas Pharma Inc. Jpn
-
Mutoh Seitaro
Pharmacology Research Laboratories Astellas Pharma Inc.
-
MAKI Katsuyuki
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
WATABE Etsuko
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
IGUCHI Yumi
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
MATSUMOTO Satoru
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
IKEDA Fumiaki
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
TAWARA Shuichi
Pharmacology Research Laboratories, Astellas Pharma, Inc.
-
NAKAMURA Hideko
Chemistry Research Laboratories, Astellas Pharma, Inc.
-
TOMISHIMA Masaki
Chemistry Research Laboratories, Astellas Pharma, Inc.
-
OHKI Hidenori
Chemistry Research Laboratories, Astellas Pharma, Inc.
-
YAMADA Akira
Chemistry Research Laboratories, Astellas Pharma, Inc.
-
Iguchi Yumi
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Watabe Etsuko
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Ohki Hidenori
Chemistry Research Laboratories Astellas Pharma Inc.
-
Ikeda F
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Tawara S
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Matsumoto S
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Maki Katsuyuki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Matsumoto Satoru
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Nakamura Hideko
Chemistry Research Laboratories Astellas Pharma Inc.
-
Tomishima Masaki
Chemistry Research Laboratories Astellas Pharma Inc.
-
Yamada Akira
Chemistry Research Laboratories Astellas Pharma Inc.
-
Tawara Shuichi
Pharmacology Research Laboratories Astellas Pharma Inc.
-
IKEDA Fumiaki
Pharmacology Research Laboratories Astellas Pharma Inc.
関連論文
- Novel Method for Selecting Immunosuppressive Histone Deacetylase (HDAC) Inhibitors with Minimal Thrombocytopenia(Molecular and Cell Biology)
- Tacrolimus (FK506) Limits Accumulation of Granulocytes and Platelets and Protects against Brain Damage after Transient Focal Cerebral Ischemia in Rat(Pharmacology)
- A Multidimensional Cubic-Interpolated Pseudoparticle (CIP) Method Without Time Splitting Technique for Hyperbolic Equations
- Unique Properties of Coactivator Recruitment Caused by Differential Binding of FK614, an Anti-diabetic Agent, to Peroxisome Proliferator-Activated Receptor γ(Molecular and Cell Biology)
- FK614, a Novel Peroxisome Proliferator-Activated Receptor γ Modulator, Induces Differential Transactivation Through a Unique Ligand-Specific Interaction With Transcriptional Coactivators
- Efficacy of Oral Treatment With Tacrolimus in the Renal Transplant Model in Cynomolgus Monkeys
- Effect of a New Immunosuppressant Histon Deacetylase (HDAC) Inhibitor FR276457 in a Rat Cardiac Transplant Model(Pharmacology)
- Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations
- Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
- In Vivo Antibacterial Activity of FK041, a New Orally Active Cephalosporin
- In Vitro Antibacterial Activity of FK041, a New Orally Active Cephalosporin
- New Antitumor Substances, FR901463, FR901464 and FR901465 II. Activities against Experimental Tumors in Mice and Mechanism of Action
- Novel Amidine Conjugates of the Ornithine Moiety of the Macrocyclic Antifungal Lipopeptidolactone FR901469
- Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
- Synthesis and Biological Properties of a Novel Cephalosporin FR86521 Having Potent Activity Against Methicillin-resistant Staphylococcus aureus (MRSA)
- Anti-cachectic Effect of FK317, a Novel Anti-cancer Agent, in Colon26 and LX-1 Models in Mice
- FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice
- Different Effects of FK317 on Multidrug-resistant Tumor in vivo and in vitro
- Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
- A New Aromatase Inhibitor, FR901537 II.Pharmacological and Antitumor Effects
- FR192752, a Novel Orally Active Cephalosporin Synthesis and Biological Properties
- FK463, a Novel Water-soluble Echinocandin Lipopetide: Synthesis and Antifungal Activity
- FK041, a Novel Orally Active Cephalosporin: Synthesis and Biological Properties
- Studies on 3'-Quaternary Ammonium Cephalosporins II Synthesis and Antibacterial Activity of 7β-[(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin Derivatives Bearing Various Ouaternary Ammonium Methyl Groups at the 3 Position
- Direct Observation of a Central Bare Zone in a Native Thick Filament Isolated from the Anterior Byssus Retractor Muscle of Mytilus edulis Using Fluorescent ATP Analogue
- In Vitro Antibacterial Activity of a New Cephalosporin, FR295389, against IMP-type Metallo-β-lactamase-producers
- Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds
- The Size of cagA Based on Repeat Sequence Has the Responsibility of the Location of Helicobacter pylori in the Gastric Mucus and the Degree of Gastric Mucosal Inflammation